Twist Bioscience Corp (TWST)
42.23
+0.57
(+1.37%)
USD |
NASDAQ |
Nov 22, 16:00
42.26
+0.03
(+0.07%)
After-Hours: 20:00
Twist Bioscience Enterprise Value: 2.230B for Nov. 22, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 22, 2024 | 2.230B |
| November 21, 2024 | 2.196B |
| November 20, 2024 | 2.164B |
| November 19, 2024 | 2.176B |
| November 18, 2024 | 2.183B |
| November 15, 2024 | 1.913B |
| November 14, 2024 | 2.036B |
| November 13, 2024 | 2.246B |
| November 12, 2024 | 2.388B |
| November 11, 2024 | 2.507B |
| November 08, 2024 | 2.397B |
| November 07, 2024 | 2.404B |
| November 06, 2024 | 2.398B |
| November 05, 2024 | 2.264B |
| November 04, 2024 | 2.199B |
| November 01, 2024 | 2.171B |
| October 31, 2024 | 2.100B |
| October 30, 2024 | 2.266B |
| October 29, 2024 | 2.235B |
| October 28, 2024 | 2.227B |
| October 25, 2024 | 2.114B |
| October 24, 2024 | 2.093B |
| October 23, 2024 | 2.143B |
| October 22, 2024 | 2.303B |
| October 21, 2024 | 2.394B |
| Date | Value |
|---|---|
| October 18, 2024 | 2.487B |
| October 17, 2024 | 2.404B |
| October 16, 2024 | 2.377B |
| October 15, 2024 | 2.450B |
| October 14, 2024 | 2.470B |
| October 11, 2024 | 2.342B |
| October 10, 2024 | 2.176B |
| October 09, 2024 | 2.164B |
| October 08, 2024 | 2.228B |
| October 07, 2024 | 2.205B |
| October 04, 2024 | 2.275B |
| October 03, 2024 | 2.243B |
| October 02, 2024 | 2.272B |
| October 01, 2024 | 2.279B |
| September 30, 2024 | 2.384B |
| September 27, 2024 | 2.428B |
| September 26, 2024 | 2.469B |
| September 25, 2024 | 2.386B |
| September 24, 2024 | 2.432B |
| September 23, 2024 | 2.364B |
| September 20, 2024 | 2.431B |
| September 19, 2024 | 2.522B |
| September 18, 2024 | 2.465B |
| September 17, 2024 | 2.503B |
| September 16, 2024 | 2.438B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
268.48M
Minimum
May 02 2023
9.527B
Maximum
Jan 20 2021
2.473B
Average
1.891B
Median
Mar 06 2024
Enterprise Value Benchmarks
| Microbot Medical Inc | 12.26M |
| Perspective Therapeutics Inc | -31.63M |
| Retractable Technologies Inc | -16.44M |
| Xtant Medical Holdings Inc | 83.10M |
| Catheter Precision Inc | 3.859M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -34.66M |
| Revenue (Quarterly) | 84.71M |
| Total Expenses (Quarterly) | 120.75M |
| EPS Diluted (Quarterly) | -0.59 |
| Gross Profit Margin (Quarterly) | 45.13% |
| Profit Margin (Quarterly) | -40.91% |
| Earnings Yield | -8.52% |
| Normalized Earnings Yield | -7.079 |